AI News about cancer treatment

Latest news and AI summaries about cancer treatment · 3 articles

About cancer treatment

Latest AI-curated news and analysis about cancer treatment, including breaking stories, expert analysis, and global coverage. Updated in real-time with AI-powered summaries to keep you informed.

Related: technology · mercy hospital · edison histotripsy system · tumor removal · incisionless surgery

Trending Topics

Mercy Hospital introduces incisionless tumor removal technology
technologyAI Summary

Mercy Hospital introduces incisionless tumor removal technology

Mercy Hospital First in Region to Offer Incisionless Tumor Removal Mercy Hospital in St. Louis has become among the first hospitals nationally to deploy the Edison Histotripsy System, a breakthrough technology that removes tumors without surgical incisions. This noninvasive approach uses focused ultrasound waves to destroy tumors while preserving surrounding healthy tissue. The adoption represents a significant advancement in cancer treatment options for patients in the region.

FOX 2 · 2026.04.02

The Intersection of Technology and Psycho-Oncology Care
technologyAI Summary

The Intersection of Technology and Psycho-Oncology Care

Tech-Enhanced Care Reduces Depression in Cancer Patients The SCOPE trial, led by Dr. Jesse Fann, demonstrates how technology-enabled collaborative care effectively treats depression in active cancer patients. This breakthrough integrates mental health support into oncology treatment, addressing a critical gap in psycho-oncology. Results suggest digital tools can significantly improve patient outcomes during cancer therapy.

Cancer Network · 2026.03.25

Groundbreaking Developments in Health and Pharmaceutical Sector | Health
healthAI Summary

Groundbreaking Developments in Health and Pharmaceutical Sector | Health

FDA Streamlines Biosimilar Testing, Slashing Drug Costs The FDA has introduced new guidelines to streamline biosimilar drug testing, dramatically reducing costs for vital biologic medications used in cancer treatment and other diseases. Despite biosimilars representing only 5% of prescriptions, they account for 51% of total drug expenditure. These regulatory changes aim to make life-saving treatments more accessible and affordable.

Devdiscourse · 2026.03.11

Related Topics

More Topics